Stenotrophomonas maltophilia septicemia with pyomyositis in a chemotherapy-treated patient.

Abstract

Pyomyositis is a rare complication of chemotherapy. A 35-year-old male patient with myelodysplastic syndrome developed Stenotrophomonas maltophilia bacteremia shortly after chemotherapy, and Stenotrophomonas maltophilia-related pyomyositis was encountered after recovery from neutropenia. He recovered completely after surgical drainage and a protracted course of antibiotic treatment. It is postulated that subclinical myopathy, immunosuppression secondary to the malignancy, or chemotherapeutic drugs may predispose to pyomyositis. Early recognition of this unusual complication in a cancer patient undergoing chemotherapy can prevent further catastrophes.

• Authors: S H Tsai, T Y Chao, T D Chou, M S Dai
• Journal: Annals of hematology (Ann Hematol) Vol. 82 Issue 7 Pg. 452-4 (Jul 2003) ISSN: 0939-5555 [Print] Germany
• PMID: 12750843 (Publication Type: Case Reports, Journal Article)

Chemical References

• Antineoplastic Agents

Topics

• Adult
• Antineoplastic Agents (adverse effects)
• Diagnosis, Differential
• Humans
• Leg (pathology)
• Magnetic Resonance Imaging
• Male
• Myelodysplastic Syndromes (complications, drug therapy)
• Myositis (chemically induced, diagnosis, therapy)
• Opportunistic Infections
• Sepsis (chemically induced, diagnosis, therapy)
• Stenotrophomonas maltophilia